Global Craniomaxilofacial Device Market Forecasted CAGR 7.2% Growth by 2024 | A report by Stryker Corporation, Medtronic PLC, Johnson & Johnson, KLS Martin, Depuy Synthes, Zimmer Biomet Holdings and others

Global Craniomaxillofacial Devices Market is expected to grow from its initial estimated value of USD 1.39 billion in 2018 to a projected value of USD 2.52 billion by 2026, registering a CAGR of 7.70% in the forecast period of 2019-2026. This rise in market value can be attributed to rise in innovations and advancements in the product and devices offerings.

Key Competitors:
Few of the major competitors currently present in the market are Johnson & Johnson Services, Inc.; Stryker; Medartis AG; Zimmer Biomet; B. Braun Melsungen AG; Invibio Ltd.; Antibe Therapeutics Inc.; GENERAL ELECTRIC; Matrix Surgical USA; Summit Medical Group; Integra LifeSciences; CONMED Corporation; KLS Martin Group; Medtronic; TMJ Concepts; OsteoMed and W. L. Gore & Associates, Inc.

Download Sample PDF Report https://databridgemarketresearch.com/request-a-sample/?dbmr=global-craniomaxilofacial-devices-market

Major Market Drivers and Restraints:
• Rising incidences of road accidents and trauma cases
• Rising awareness and demand for minimally invasive reconstruction surgeries
• Technological advancements and rising healthcare expenditure
• High cost of craniomaxillofacial surgeries

Key Developments in the Market:

In September 2017, Johnson & Johnson Services, Inc. through its subsidiary DePuy Synthes announced the launch of 3D produced titanium-based facial surgical implants for the United States market. The product termed as “TRUMATCH Titanium 3D-Printed Implants” will be commercially distributed through a specialized distributor.
In June 2017, Summit Medical Group announced the launch of US FDA cleared maxilla-mandibular fixation (MMF) device, termed as “Minnie Ties Agile MMF”. The product is a first of its kind as it is a non-invasive product for use in jaw fractures.
In January 2017, Antibe Therapeutics Inc. announced the launch of “PentOS OI Max” company’s new bone graft substitute for use in dental biologics market.

Competitive Analysis:
Global craniomaxillofacial devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of craniomaxillofacial devices market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Speak To Author https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-craniomaxilofacial-devices-market

Segmentation:
By product
• Cranial flap fixation
• cmf distraction
• tmj replacement
• thoracic fixation
• bone graft substitute.

By material
• polymers
• bioabsorbable
• metals
• alloys and ceramic calcium

On the basis of nature
• Reabsorbable
• Non-reabsorbable

By application
• neurosurgery and ent
• orthognathic and dental
• plastic surgery

End-user
• hospitals
• ambulatory surgical centers
• clinics

Geography
• North America
• South America
• Europe
• Asia-Pacific
• Middle East & Africa

Countries
• U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

…And More GET DETAILED TOC AT: https://databridgemarketresearch.com/toc/?dbmr=global-craniomaxilofacial-devices-market

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.